AKT1 and MYC induce distinctive metabolic fingerprints in human prostate cancer
Cancer cells may overcome growth factor dependence by deregulating oncogenic and/or tumor-suppressor pathways that affect their metabolism, or by activating metabolic pathways de novo with targeted mutations in critical metabolic enzymes. It is unknown whether human prostate tumors develop a similar...
Guardado en:
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Articulo |
| Lenguaje: | Inglés |
| Publicado: |
2014
|
| Materias: | |
| Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/85055 |
| Aporte de: |
| id |
I19-R120-10915-85055 |
|---|---|
| record_format |
dspace |
| institution |
Universidad Nacional de La Plata |
| institution_str |
I-19 |
| repository_str |
R-120 |
| collection |
SEDICI (UNLP) |
| language |
Inglés |
| topic |
Ciencias Médicas Cáncer Espectrometría de Masas AKT1 MYC |
| spellingShingle |
Ciencias Médicas Cáncer Espectrometría de Masas AKT1 MYC Priolo, C. Pyne, S. Rose, J. Regan, E.R. Zadra, G. Photopoulos, C. Cacciatore, S. Schultz, D. Scaglia, Natalia McDunn, J. De Marzo, A.M. Loda, M. AKT1 and MYC induce distinctive metabolic fingerprints in human prostate cancer |
| topic_facet |
Ciencias Médicas Cáncer Espectrometría de Masas AKT1 MYC |
| description |
Cancer cells may overcome growth factor dependence by deregulating oncogenic and/or tumor-suppressor pathways that affect their metabolism, or by activating metabolic pathways de novo with targeted mutations in critical metabolic enzymes. It is unknown whether human prostate tumors develop a similar metabolic response to different oncogenic drivers or a particular oncogenic event results in its own metabolic reprogramming. Akt and Myc are arguably the most prevalent driving oncogenes in prostate cancer. Mass spectrometry-based metabolite profiling was performed on immortalized human prostate epithelial cells transformed by AKT1 or MYC, transgenic mice driven by the same oncogenes under the control of a prostate-specific promoter, and human prostate specimens characterized for the expression and activation of these oncoproteins. Integrative analysis of these metabolomic datasets revealed that AKT1 activation was associated with accumulation of aerobic glycolysis metabolites, whereas MYC overexpression was associated with dysregulated lipid metabolism. Selected metabolites that differentially accumulated in the MYC-high versus AKT1-high tumors, or in normal versus tumor prostate tissue by untargeted metabolomics, were validated using absolute quantitation assays. Importantly, the AKT1/MYC status was independent of Gleason grade and pathologic staging. Our fi ndings show how prostate tumors undergo a metabolic reprogramming that refl ects their molecular phenotypes, with implications for the development of metabolic diagnostics and targeted therapeutics. |
| format |
Articulo Articulo |
| author |
Priolo, C. Pyne, S. Rose, J. Regan, E.R. Zadra, G. Photopoulos, C. Cacciatore, S. Schultz, D. Scaglia, Natalia McDunn, J. De Marzo, A.M. Loda, M. |
| author_facet |
Priolo, C. Pyne, S. Rose, J. Regan, E.R. Zadra, G. Photopoulos, C. Cacciatore, S. Schultz, D. Scaglia, Natalia McDunn, J. De Marzo, A.M. Loda, M. |
| author_sort |
Priolo, C. |
| title |
AKT1 and MYC induce distinctive metabolic fingerprints in human prostate cancer |
| title_short |
AKT1 and MYC induce distinctive metabolic fingerprints in human prostate cancer |
| title_full |
AKT1 and MYC induce distinctive metabolic fingerprints in human prostate cancer |
| title_fullStr |
AKT1 and MYC induce distinctive metabolic fingerprints in human prostate cancer |
| title_full_unstemmed |
AKT1 and MYC induce distinctive metabolic fingerprints in human prostate cancer |
| title_sort |
akt1 and myc induce distinctive metabolic fingerprints in human prostate cancer |
| publishDate |
2014 |
| url |
http://sedici.unlp.edu.ar/handle/10915/85055 |
| work_keys_str_mv |
AT prioloc akt1andmycinducedistinctivemetabolicfingerprintsinhumanprostatecancer AT pynes akt1andmycinducedistinctivemetabolicfingerprintsinhumanprostatecancer AT rosej akt1andmycinducedistinctivemetabolicfingerprintsinhumanprostatecancer AT reganer akt1andmycinducedistinctivemetabolicfingerprintsinhumanprostatecancer AT zadrag akt1andmycinducedistinctivemetabolicfingerprintsinhumanprostatecancer AT photopoulosc akt1andmycinducedistinctivemetabolicfingerprintsinhumanprostatecancer AT cacciatores akt1andmycinducedistinctivemetabolicfingerprintsinhumanprostatecancer AT schultzd akt1andmycinducedistinctivemetabolicfingerprintsinhumanprostatecancer AT scaglianatalia akt1andmycinducedistinctivemetabolicfingerprintsinhumanprostatecancer AT mcdunnj akt1andmycinducedistinctivemetabolicfingerprintsinhumanprostatecancer AT demarzoam akt1andmycinducedistinctivemetabolicfingerprintsinhumanprostatecancer AT lodam akt1andmycinducedistinctivemetabolicfingerprintsinhumanprostatecancer |
| bdutipo_str |
Repositorios |
| _version_ |
1764820488896380930 |